Nils Winkelmann

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Rocco Piazza, Simona Valletta, Nils Winkelmann et al. · Nature Genetics · 2012 · 422 citations · Full text

Hematological Malignancy, Hematology, Medicine +4

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

David Oscier, Matthew Rose‐Zerilli, Nils Winkelmann et al. · Blood · 2012 · 206 citations

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Joannah Score, Claire Hidalgo-Curtis, Amy V. Jones et al. · Blood · 2011 · 171 citations · Full text

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status

Mathias Schmidt, Jenny Rinke, Vivien Schäfer et al. · Leukemia · 2014 · 139 citations

Hematological Malignancy, Tumor Biology, Molecular-defined Clonal Evolution +13